Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-25

Clinical Trial Update: Serosurvey of HAV Immunity and Single-dose Vaccine Immunogenicity Among Patients With Cirrhosis

View source ↗

Summary

This clinical trial evaluates hepatitis A immunity and the immunogenicity of a single-dose HAV vaccine in patients with cirrhosis; the study status is NOT_YET_R…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hepatitis A vaccine (inactivated Hepatitis A vaccine)

Snippet

Sponsor: Institute of Liver and Biliary Sciences, India | Conditions: Liver Cirrhosis | Status: NOT_YET_RECRUITING